Tirzepatide is the newest FDA-approved prescription medication that promotes weight loss by suppressing appetite, causing a reduction in food intake. This medication mimics the GLP-1 and GIP hormones, regulating your appetite and blood sugar levels.
Tirzepatide causes your insulin production to become more efficient and makes you feel satisfied with a lower food intake. Over time, and with the proper combination of a balanced diet and exercise, Tirzepatide can offer significant weight loss results in shorter time frames.
In the SURMOUNT-1 study, Tirzepatide reduced body weight by up to 21% after 72 weeks of treatment, with associated improvements in cardiometabolic risk factors.
Just like Semaglutide, this medication is also proven to help reduce the risk of cancer, diabetes, and heart disease in people who are overweight or dealing with obesity.
At PhySlim, we combine this innovative treatment with a comprehensive health perspective that encourages implementing healthy habits into your routine.